Australia's IVF industry is booming, but major scandals and cyberattacks are putting patient trust, and future growth, to the test.
Background:
IVF has been around since the 1970s, when Monash University scientists produced one of the world's first IVF pregnancies.
What’s changed since then, is who's using it. Same-sex couples, single people looking to start a family, and older first-time parents are all now able to have children using IVF. But, as society shifts, people are opting to have children later than they ever have before.
In Australia, the median age for mothers giving birth in 2024 was 32.1 years. That's a record high and up more than a year since 2014. Egg freezing has also grown 60% over the past decade all around the world… to one of the fastest-growing segments in the entire fertility sector.
Where we're at today:
The Australian IVF market is worth approximately $730 million annually. That's projected to reach $1.6 billion by 2033 at an 8.5% annual growth rate.
Which means roughly 100,000 assisted reproductive cycles are taking place in Australia every year.
And in the Australian market, three major players have more than 80% market share in the fertility space:
They’ve all expanded their offerings to everything around conception too. There’s genetics testing, sperm banking, donor programs and day surgery facilities. Which means patients can go from an initial consultation to egg retrieval to genetic screening to transfer without leaving the company.
Where to from here:
These companies have suffered from some major controversies in recent years.
In April 2025, Monash IVF disclosed that a patient at its Brisbane clinic had received the wrong embryo in 2023, resulting in a birth (which was only discovered two years later). Just a few months after, a second incident was disclosed where a patient received their own embryo instead of their partner's.
By mid-2025, Monash IVF’s stock had fallen more than 50% below its pre-April value.
And in February 2025, Genea, Australia's third-largest IVF provider, suffered a cyberattack... where hackers stole patient Medicare numbers, medical histories, diagnoses, medications, cycle data, and pathology results and published it on the dark web.
So now stronger compliance regulations are being placed on the entire industry... and it means the big players need financial support to fund things like independent audits, stricter lab verification, and mandatory incident reporting. But scale doesn't automatically equal trust - and in this sector, trust is a huge part of the service.
Patients are often going through one of the most physically and psychologically demanding periods of their lives. So, when trust breaks down, patients vote with their feet. Monash's new patient registrations fell 12% in the months following the scandals. And their market share dropped from 21.5% to 19% in just one half (the sharpest decline in its history as a listed company).
Now the entire sector now has to prove that it can deliver reliably at one of the most stressful moments in people's lives. And not just to the regulators, but to prospective patients too
Sign up for Flux and join 100,000 members of the Flux family
